Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
NIAID-supported research sheds light on why healthy people of the same age respond differently to vaccines.
Fauci, who has directed the National Institute of Allergy and Infectious Diseases since 1984, will step down in December.
The small study found no evidence of delayed development of antibodies in participants who experienced rebound after taking Paxlovid.
Higher levels of viral antigens in the blood correlated with more severe disease.
Fauci led the U.S. HIV research effort for nearly 40 years before becoming the nation’s leading COVID-19 medical advisor.
What have we learned from the COVID-19 pandemic, and what’s the future of HIV vaccine research? Find out this #HVAD2022.
The HVTN 302 trial is evaluating experimental vaccines that deliver stabilized HIV spike proteins.
New vaccine approach triggers neutralizing antibody production and T-cell responses and lowers risk of infection.
Elton John and global leaders honor the infectious disease expert with a lifetime achievement award.
The trial is evaluating an investigational vaccine from Janssen that may require only one shot.
The trial will enroll healthy volunteers to test the vaccine’s safety and ability to trigger an immune response.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.